Blood Test for Alzheimer's Granted Breakthrough Device Status by FDA
A blood test for the phosphorylated protein pTau-217 could be a critical step towards early diagnosis and screening of Alzheimer's disease.
New MND Early Diagnostic Test: a 'Game-Changer' for Research on the Disease
Detecting the aggregation of TDP-43 spells a new diagnostic tool for MND.
The Power of Real-World Data Analytics in Biomarker Discovery: A Game-Changer in Medical Research
Biomarker discovery in medical research traditionally relied on controlled trials. Now, Real-World Data Analytics offers a transformative approach, analyzing real-world patient data to identify new biomarkers and improve patient care.
Speech-Analysis Tool for the Early Detection of Alzheimer's Handed to Linus Health in Acquisition
Aural Analysis's Speech Vitals and Linus Health's expansion into linguistic analysis herald a promising era in early detection and treatment.
Abcam: Cancer Biomarkers Guide
Merck: Analyte Quarterly
Meet Our Expert Speakers
The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Biomarkers 2024: 29 February - 01 March 2024, London, UK
Alexandra Sevko
Director,
Prokarium
Anders Ståhlberg
Professor,
University of Gothenburg
David Krige
Head translational sciences,
Accession therapeutics
.jpg?length=600&name=b7719967-873f-42b2-88c6-fd37874958aa-2-11764368speaker_photo-Sanderink_Gerard_0646-(2).jpg)
Gerard Sanderink
Global Head Biomarkers & Clinical Bioanalysis,
Sanofi
Henoch Hong
Associate Director,
Merck Healthcare KGaA
Kimberly Kraynyak
Principal Scientist, Translational Oncology,
Merck Life Science KGaA
Kira Holmstrom
Head of Biomarker Research,
Herantis Pharma
Kon Yew Kwek
Senior Vice President and Clinical Development,
Hummingbird Bioscience
Paul Skipp
Professor of Proteomics,
University of Southampton
All Speakers
Amanda Heslegrave
Senior Research Fellow,
University College London
Andrew Pierce
Vice President, Translational Biology,
Crescendo Biologics
Anna Ettorre
Director of Translational Science,
AviadoBio Ltd
Anne Remaury
Principal Scientist in Bioanalysis,
Sanofi
Bangwen Xie
Clinical Biomarker Data Operations Manager,
GSK R&D
Belinda Nedjai
Associate Professor,
Queen Mary University of London
Chris Chamberlain
Head of Precision Medicine Discovery and Development,
AstraZeneca
Christopher Peters
Clinical Senior Lecturer,
Imperial College London
Debayan Mukherjee
Principal Scientist,
GSK
Desiree Schenk
Principal Scientist,
Gritstone Oncology
Dmitri Mikhailov
Director,
Novartis
Donna Finch
Head of Translational and Clinical Science,
Alchemab Therapeutics
Elizabeth Harrington
Executive Director, Translational Medicine,
AstraZeneca
Emilyanne Leonard
Associate Director,
AstraZeneca
Emma Leire
Director Translational Biomarkers,
Achilles Tx
Gabriela Kramer-Marek
Group Leader,
The Institute of Cancer Research
Gad Simchoni Cojocaru
scientist,
Cgen
Giovanna Lalli
Director, Strategy & Operations,
LifeArc
Graham Ball
Director of the Medical Technology Research Centre,
Anglia Ruskin University
Hans-Dieter Volk
prof,
charité
Irene del Molino del Barrio
Principal Scientist,
GSK
Jeremy Magnanensi
Project Manager - Biostatistician Biomarkers R&D,
Genfit
Jose MG Izarzugaza
Head of Department,
Novo Nordisk
Kathrin Heinzmann
Biomarker Scientist,
Cancer Research UK
Kiri Granger
Chief Scientific Officer,
Monument Therapeutics
Kristian Moss Bendtsen
Data Scientist,
Novo Nordisk
Leonor Benhaim
Doctor,
INSERM
Malgorzata Oczko-Wojciechowska
Professor,
Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch
Maria Udriste
Senior Scientist,
AstraZeneca
Mohamed Hassanein
Director, Translational Medicine,
Pfizer
Patrick Fivey
Director of Precision Medicine Policy,
AstraZeneca
Rita Vicente
Senior Principal Scientist, Head of the Immunology Laboratory,
Sanofi
Rupesh Kanchi Ravi
Senior Director, ADO,
Fulgent Pharma
Stephanie Craig
Lecturer in Precision Medicine,
Queen's University Belfast
Steven Piccoli
Head of Clinical Biomarkers,
SPARC
Steven Piccoli
Head of Clinical Biomarkers,
SPARC
Thomas Jensen
Chief Executive Officer,
Allarity
Thomas Hach
Executive Director Patient Engagement, Cardiovascular, Renal & Metabolism Patient Engagement,,
Novartis
Tim Aitman
Professor of Molecular Pathology and Genetics,
University of Edinburgh